Annual Net Income
-$59.08 M
+$3.14 M+5.05%
December 31, 2023
Summary
- As of February 7, 2025, GRTX annual net profit is -$59.08 million, with the most recent change of +$3.14 million (+5.05%) on December 31, 2023.
- During the last 3 years, GRTX annual net income has risen by +$15.14 million (+20.39%).
- GRTX annual net income is now -150.93% below its all-time high of -$23.55 million, reached on December 31, 2017.
Performance
GRTX Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Net Income
-$5.58 M
-$1.52 M-37.33%
September 1, 2024
Summary
- As of February 7, 2025, GRTX quarterly net profit is -$5.58 million, with the most recent change of -$1.52 million (-37.33%) on September 1, 2024.
- Over the past year, GRTX quarterly net income has increased by +$6000.00 (+0.11%).
- GRTX quarterly net income is now -37.33% below its all-time high of -$4.06 million, reached on June 30, 2024.
Performance
GRTX Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Net Income
-$19.61 M
+$9.49 M+32.61%
September 1, 2024
Summary
- As of February 7, 2025, GRTX TTM net profit is -$19.61 million, with the most recent change of +$9.49 million (+32.61%) on September 1, 2024.
- Over the past year, GRTX TTM net income has increased by +$39.47 million (+66.80%).
- GRTX TTM net income is now -273.65% below its all-time high of -$5.25 million, reached on September 30, 2018.
Performance
GRTX TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Net Income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
GRTX Net Income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +5.0% | +0.1% | +66.8% |
| 3 y3 years | +20.4% | +0.1% | +66.8% |
| 5 y5 years | -149.5% | +0.1% | +66.8% |
GRTX Net Income Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +26.6% | -37.3% | +73.0% | at high | +75.7% |
| 5 y | 5-year | -13.8% | +26.6% | -37.3% | +75.3% | at high | +76.6% |
| alltime | all time | -150.9% | +26.6% | -37.3% | +75.3% | -273.6% | +76.6% |
Galera Therapeutics Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$5.58 M(+37.3%) | -$19.61 M(-32.6%) |
| Jun 2024 | - | -$4.06 M(-7.2%) | -$29.11 M(-36.4%) |
| Mar 2024 | - | -$4.38 M(-21.6%) | -$45.75 M(-22.6%) |
| Dec 2023 | -$59.08 M(-5.0%) | -$5.59 M(-62.9%) | -$59.08 M(-15.2%) |
| Sep 2023 | - | -$15.07 M(-27.2%) | -$69.68 M(-1.4%) |
| Jun 2023 | - | -$20.71 M(+17.0%) | -$70.64 M(+9.5%) |
| Mar 2023 | - | -$17.71 M(+9.4%) | -$64.49 M(+3.6%) |
| Dec 2022 | -$62.22 M(-22.7%) | -$16.19 M(+1.0%) | -$62.22 M(-1.0%) |
| Sep 2022 | - | -$16.03 M(+10.1%) | -$62.84 M(-9.5%) |
| Jun 2022 | - | -$14.56 M(-5.7%) | -$69.43 M(-10.1%) |
| Mar 2022 | - | -$15.44 M(-8.1%) | -$77.26 M(-4.1%) |
| Dec 2021 | -$80.53 M | -$16.81 M(-25.7%) | -$80.53 M(-3.9%) |
| Sep 2021 | - | -$22.63 M(+1.1%) | -$83.79 M(+7.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2021 | - | -$22.39 M(+19.6%) | -$78.25 M(+5.0%) |
| Mar 2021 | - | -$18.71 M(-6.7%) | -$74.52 M(+0.4%) |
| Dec 2020 | -$74.22 M(+42.9%) | -$20.07 M(+17.5%) | -$74.22 M(+4.8%) |
| Sep 2020 | - | -$17.08 M(-8.5%) | -$70.82 M(+5.6%) |
| Jun 2020 | - | -$18.66 M(+1.3%) | -$67.10 M(+11.8%) |
| Mar 2020 | - | -$18.42 M(+10.5%) | -$60.00 M(+15.5%) |
| Dec 2019 | -$51.93 M(+119.3%) | -$16.67 M(+24.9%) | -$51.93 M(+18.5%) |
| Sep 2019 | - | -$13.35 M(+15.5%) | -$43.82 M(+22.7%) |
| Jun 2019 | - | -$11.56 M(+11.7%) | -$35.72 M(+47.8%) |
| Mar 2019 | - | -$10.35 M(+20.9%) | -$24.16 M(+74.9%) |
| Dec 2018 | -$23.68 M(+0.6%) | -$8.56 M(+63.1%) | -$13.81 M(+163.1%) |
| Sep 2018 | - | -$5.25 M | -$5.25 M |
| Dec 2017 | -$23.55 M | - | - |
FAQ
- What is Galera Therapeutics annual net profit?
- What is the all time high annual net income for Galera Therapeutics?
- What is Galera Therapeutics annual net income year-on-year change?
- What is Galera Therapeutics quarterly net profit?
- What is the all time high quarterly net income for Galera Therapeutics?
- What is Galera Therapeutics quarterly net income year-on-year change?
- What is Galera Therapeutics TTM net profit?
- What is the all time high TTM net income for Galera Therapeutics?
- What is Galera Therapeutics TTM net income year-on-year change?
What is Galera Therapeutics annual net profit?
The current annual net income of GRTX is -$59.08 M
What is the all time high annual net income for Galera Therapeutics?
Galera Therapeutics all-time high annual net profit is -$23.55 M
What is Galera Therapeutics annual net income year-on-year change?
Over the past year, GRTX annual net profit has changed by +$3.14 M (+5.05%)
What is Galera Therapeutics quarterly net profit?
The current quarterly net income of GRTX is -$5.58 M
What is the all time high quarterly net income for Galera Therapeutics?
Galera Therapeutics all-time high quarterly net profit is -$4.06 M
What is Galera Therapeutics quarterly net income year-on-year change?
Over the past year, GRTX quarterly net profit has changed by +$6000.00 (+0.11%)
What is Galera Therapeutics TTM net profit?
The current TTM net income of GRTX is -$19.61 M
What is the all time high TTM net income for Galera Therapeutics?
Galera Therapeutics all-time high TTM net profit is -$5.25 M
What is Galera Therapeutics TTM net income year-on-year change?
Over the past year, GRTX TTM net profit has changed by +$39.47 M (+66.80%)